TrialJournal of inherited metabolic disease2018

Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.

Jochen Meyburg et al.PubMed ↗Publisher ↗

No numbers read from the abstract.